These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 34977046

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of RUNX1 dosage is crucial for efficient blood formation from hemogenic endothelium.
    Lie-A-Ling M, Marinopoulou E, Lilly AJ, Challinor M, Patel R, Lancrin C, Kouskoff V, Lacaud G.
    Development; 2018 Mar 12; 145(5):. PubMed ID: 29530939
    [Abstract] [Full Text] [Related]

  • 10. RUNX1 isoforms regulate RUNX1 and target genes differentially in platelets-megakaryocytes: association with clinical cardiovascular events.
    Guan L, Voora D, Myers R, Del Carpio-Cano F, Rao AK.
    J Thromb Haemost; 2024 Dec 12; 22(12):3581-3598. PubMed ID: 39181539
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. RUNX1 Isoforms Regulate RUNX1 and Target-Genes Differentially in Platelets-Megakaryocytes: Association with Clinical Cardiovascular Events.
    Guan L, Voora D, Myers R, Del Carpio-Cano F, Rao AK.
    bioRxiv; 2024 Jun 21. PubMed ID: 38948740
    [Abstract] [Full Text] [Related]

  • 13. Runx1 is sufficient for blood cell formation from non-hemogenic endothelial cells in vivo only during early embryogenesis.
    Yzaguirre AD, Howell ED, Li Y, Liu Z, Speck NA.
    Development; 2018 Jan 29; 145(2):. PubMed ID: 29361566
    [Abstract] [Full Text] [Related]

  • 14. The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis.
    Sroczynska P, Lancrin C, Kouskoff V, Lacaud G.
    Blood; 2009 Dec 17; 114(26):5279-89. PubMed ID: 19858498
    [Abstract] [Full Text] [Related]

  • 15. Alternative translation initiation generates the N-terminal truncated form of RUNX1 that retains hematopoietic activity.
    Goyama S, Schibler J, Mulloy JC.
    Exp Hematol; 2019 Apr 17; 72():27-35. PubMed ID: 30690039
    [Abstract] [Full Text] [Related]

  • 16. The Role of Runx1 in Embryonic Blood Cell Formation.
    Yzaguirre AD, de Bruijn MF, Speck NA.
    Adv Exp Med Biol; 2017 Apr 17; 962():47-64. PubMed ID: 28299650
    [Abstract] [Full Text] [Related]

  • 17. Efficient hemogenic endothelial cell specification by RUNX1 is dependent on baseline chromatin accessibility of RUNX1-regulated TGFβ target genes.
    Howell ED, Yzaguirre AD, Gao P, Lis R, He B, Lakadamyali M, Rafii S, Tan K, Speck NA.
    Genes Dev; 2021 Nov 01; 35(21-22):1475-1489. PubMed ID: 34675061
    [Abstract] [Full Text] [Related]

  • 18. Meis1 establishes the pre-hemogenic endothelial state prior to Runx1 expression.
    Coulombe P, Cole G, Fentiman A, Parker JDK, Yung E, Bilenky M, Degefie L, Lac P, Ling MYM, Tam D, Humphries RK, Karsan A.
    Nat Commun; 2023 Jul 27; 14(1):4537. PubMed ID: 37500618
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.